Are you Dr. Bernath?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
100 N Academy Ave
Danville, PA 17822Phone+1 570-271-6045Fax+1 570-271-6542
Summary
- Dr. Albert Bernath Jr., MD is an oncologist in Danville, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania. He is affiliated with Geisinger Medical Center.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1974 - 1976
- Duke University HospitalResidency, Internal Medicine, 1972 - 1974
- University of Pittsburgh School of MedicineClass of 1972
Certifications & Licensure
- PA State Medical License 1976 - 2014
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor Start of enrollment: 2003 Jun 01
- Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2006 Feb 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCorrection to: N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCC...Winston Tan, David W. Hillman, Muhammad Salim, Donald W. Northfelt, D. M. Anderson
Annals of Oncology. 2018-01-01 - 6 citationsPhase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic b...Winston Tan, Jacob B. Allred, Muhammad Salim, Patrick J. Flynn, Paul A. S. Fishkin
Clinical Breast Cancer. 2012-04-01 - 71 citationsIncreased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatmentRobert A. Schnoll, Elisa Martinez, Kristina L. Tatum, Marcella Glass, Albert M. Bernath
Addictive Behaviors. 2011-01-01
Grant Support
- Geisinger Clinical Oncology ProgramNational Cancer Institute1990–2010
- Geisinger Clinical Oncology ProgramNational Cancer Institute1987–2007
- Community Clinical Oncology ProgramNational Cancer Institute1985–1986